ArticleJournal for immunotherapy of cancer2022

Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy.

Zaofeng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.